SCHEMBL25525838

SCHEMBL25525838

CCNC1CCC2(CC1)CN(C(C)=O)C2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 5/20 0.40
CHRM4 P08173 1/20 0.39
CHRM1 P11229 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
KDM1A O60341 1/20 0.34
CYP2D6 P10635 4/20 0.33
EPHX1 P07099 3/20 0.33
CYP3A4 P08684 3/20 0.33
TSHR P16473 2/20 0.33
USP2 O75604 1/20 0.33
HPGD P15428 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP2C19 P33261 1/20 0.33
KDM4E B2RXH2 1/20 0.32
ITGB3 P05106 1/20 0.32
ITGA2B P08514 1/20 0.32
HIF1A Q16665 1/20 0.32
HSD17B10 Q99714 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25517995 0.78 EPHX2 (0.43) EPHX2CHRM4CHRM1SMN1; SMN2CYP2D6
SCHEMBL10938895 0.77 EPHX2 (0.53) EPHX2EPHX1MAPT
SCHEMBL25594423 0.75 SMN1; SMN2 (0.39) CHRM4CHRM1SMN1; SMN2CYP2D6CYP3A4
SCHEMBL23240355 0.74 SMN1; SMN2 (0.45) EPHX2CHRM4CHRM1SMN1; SMN2CYP2D6
SCHEMBL25870355 0.74 EPHX2 (0.44) EPHX2EPHX1ALDH1A1ITGB3ITGA2B
SCHEMBL24932886 0.73 KCNH2 (0.41) ITGB3ITGA2B
SCHEMBL25157111 0.73 SMN1; SMN2 (0.44) EPHX2CHRM4CHRM1SMN1; SMN2CYP2D6
SCHEMBL17572858 0.72 CHRNB2 (0.44) EPHX2SMN1; SMN2EPHX1MAPT
SCHEMBL25009341 0.70 SMN1; SMN2 (0.41) EPHX2CHRM4CHRM1SMN1; SMN2CYP2D6
SCHEMBL13798632 0.70 EPHX2 (0.46) EPHX2EPHX1CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF VICKERS VENTURE FUND VI PTE. LTD. (SG) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF DYRK1A, DYRK1B, DYRK2 EPHX2 3475/4885CHRM4 4742/4885CHRM1 4545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.